» Articles » PMID: 9630216

Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1998 Jun 18
PMID 9630216
Citations 537
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the role of cyclooxygenase (COX) in endothelial cell migration and angiogenesis, we have used two in vitro model systems involving coculture of endothelial cells with colon carcinoma cells. COX-2-overexpressing cells produce prostaglandins, proangiogenic factors, and stimulate both endothelial migration and tube formation, while control cells have little activity. The effect is inhibited by antibodies to combinations of angiogenic factors, by NS-398 (a selective COX-2 inhibitor), and by aspirin. NS-398 does not inhibit production of angiogenic factors or angiogenesis induced by COX-2-negative cells. Treatment of endothelial cells with aspirin or a COX-1 antisense oligonucleotide inhibits COX-1 activity/expression and suppresses tube formation. Cyclooxygenase regulates colon carcinoma-induced angiogenesis by two mechanisms: COX-2 can modulate production of angiogenic factors by colon cancer cells, while COX-1 regulates angiogenesis in endothelial cells.

Citing Articles

Impaired fracture healing is associated with callus chondro-osseous junction abnormalities in periostin-null and osteopontin-null mice.

Teitelbaum M, Culbertson M, Wetterstrand C, OConnor J Exp Biol Med (Maywood). 2025; 249:10066.

PMID: 39911634 PMC: 11794000. DOI: 10.3389/ebm.2024.10066.


Secreted Phospholipases A2: Drivers of Inflammation and Cancer.

Hidalgo I, Sorolla M, Sorolla A, Salud A, Parisi E Int J Mol Sci. 2024; 25(22).

PMID: 39596471 PMC: 11594849. DOI: 10.3390/ijms252212408.


Expression of and as potential biomarkers in chronic myeloid leukemia patients in Brazil.

Kubaski Benevides A, Marin A, Wosniaki D, Oliveira R, Koerich G, Kusma B Front Oncol. 2024; 14:1443346.

PMID: 39450252 PMC: 11499243. DOI: 10.3389/fonc.2024.1443346.


Nonsteroidal Anti-inflammatory Drugs for Chemoprevention in Patients With Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis.

Farooq U, El Alayli A, Duvvuri A, Mansour R, Pasam R, Malireddy S Gastro Hep Adv. 2024; 2(7):1005-1013.

PMID: 39130765 PMC: 11308826. DOI: 10.1016/j.gastha.2023.05.009.


HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies.

Verdina A, Garufi A, DOrazi V, DOrazi G Int J Mol Sci. 2024; 25(14).

PMID: 39062921 PMC: 11277226. DOI: 10.3390/ijms25147678.